Although the role of
interleukin (IL)-6 in inflammatory diseases has been previously examined, its role in hemostasis, fibrinolysis, and coagulation during
inflammation remains to be established. The present study elucidated the role of
IL-6 in
hemostatic and coagulatory changes during severe
inflammation induced by intraperitoneal administration of
lipopolysaccharide (LPS: 1 mg/kg) using
IL-6 null (-/-) mice. After LPS challenge,
IL-6 (-/-) mice revealed significant prolongation of prothrombin time and activated partial thromboplastin time and a significant decrease in platelet counts as compared with wild type mice. LPS treatment induced marked pulmonary
hemorrhage with neutrophilic
inflammation in
IL-6 (-/-) mice, in contrast, only mild neutrophilic infiltration in WT mice confirmed by macroscopic and histological findings. The
protein levels of proinflammatory mediators, such as
IL-1 beta,
macrophage inflammatory protein (MIP)-1 alpha, MIP-2, macrophage
chemoattractant protein-1,
granulocyte/macrophage-colony-stimulating factor, and keratinocyte
chemoattractant in the lungs were significantly greater in
IL-6 (-/-) mice than in WT mice after LPS challenge. These results directly indicate that
IL-6 is protective against coagulatory and
hemostatic disturbance and subsequent pulmonary
hemorrhage induced by bacterial
endotoxin, at least partly, via the modulation of proinflammatory processes.